News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Pump Plus Glc Monitor Has Low Hypoglycemia Risk
September 22, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
MedPage Today -- Sensor-augmented pump therapy -- the foundation of the so-called "artificial pancreas" -- is better than daily insulin at improving glycated hemoglobin without increasing hypoglycemia risk among adults, according to researchers.
Twitter
LinkedIn
Facebook
Email
Print